P4C panel: Patient engagement helps drug companies define value

11/14/2013 | PharmExec.com

One topic of discussion at last week's Partnering for Cures conference was a trend toward engaging patients as well as health insurers and other payers earlier in the drug development process in an effort to find both cost-savings and advances in medicine. Venture investment is down at the same time technical breakthroughs take increasingly longer, and companies must now find ways to collaborate with payers and demonstrate the value of their inventions, AdvaMed President and CEO Stephen J. Ubl said. Patient groups should collaborate more with insurers to improve benefit assessments and should more actively develop data beyond FDA approval trials to build a body of evidence around promising therapies, Cystic Fibrosis Foundation President and CEO Bob Beall said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA